Eli Lilly SWOT Analysis

Published in Pharma and Healthcare category by MBA Skool Team

Eli Lilly is one of the leading brands in the pharma and healthcare sector. Eli Lilly SWOT analysis evaluates the brand by its strengths & weaknesses which are the internal factors along with opportunities & threats which are the external factors. Let us start the SWOT Analysis of Eli Lilly:

Eli Lilly Strengths

  1. Strong capability to create strategic alliances & marketing partnerships with other corporations
  2. Strong marketing ability such as 60 second commercial plot for drug Cialis
  3. Well developed in house R&D capability
  4. Global footprint & ability to sell drugs all over the world
  5. They employ more than 7000 people in LRL spanning 50 countries
  6. Products available in over 125 countries and has close to 40,000 employees

Above are the strengths in the SWOT Analysis of Eli Lilly. The strengths of Eli Lilly looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.

Eli Lilly Weaknesses

  1. Loss of patents in US & other major markets affects performance
  2. Drop sales because of new generic products
  3. Eli lilly has captured fragmented market shares which prevents it from becoming market leader

These were the weaknesses in the Eli Lilly SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.

Eli Lilly Opportunities

  1. Improvement  global living standards
  2. Increasing awareness about healthcare needs
  3. Global societies growing older

Above we covered the opportunities in Eli Lilly SWOT Analysis. The opportunities for any brand can include prospects of future growth.

Eli Lilly Threats

  1. Over the years there is considerable increase in generic
  2. Economic slow down
  3. Increased hurdles for drug discovery & development

The threats in the SWOT Analysis of Eli Lilly are as mentioned above. The threats for any business can be external factors which can negatively impact its business.

Hence this concludes the Eli Lilly SWOT analysis.

Continue reading more about the brand/company.

About Eli Lilly

The table below gives the brand overview along with its target market, segmentation, positioning & USP

Eli Lilly Overview
Parent Company

Eli Lilly & Co

Category

Pharmaceutical  & chemical

Sector

Pharma and Healthcare

Tagline/ Slogan

Transforming challenges in advances

USP

Lilly makes medicines that help people live longer, healthier, more active lives.

Eli Lilly STP
Segmentation

They operate in Oncology, cardiovascular diseases, diabetes, critical care, neuroscience, men’s health, and musculoskeletal segments.

Target Market

Healthcare professionals offering solutions to patients suffering from oncology, diabetes, neuroscience

Positioning

Lilly makes medicines that help people live longer, healthier, more active lives.


This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Browse marketing analysis of more brands and companies similar to Eli Lilly. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.

Continue Reading:


The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin